INC.;SUNESIS PHARMACEUTICALS, INC.;SUNESIS PHARMACEUTICALS;BIOGEN MA INC
发明人:
BRIAN T. HOPKINS,BIN MA,TIMOTHY RAYMOND CHAN,LIHONG SUN,LEI ZHANG,GNANASAMBANDAM KUMARAVEL,JOSEPH P. LYSSIKATOS,KEVIN KOCH,HUA MIA0
申请号：
CL2016001435
公开号：
CL2016001435A1
申请日:
2016.06.10
申请国别(地区):
CL
年份:
2017
代理人:
摘要：
<； p >； biaryl Compounds, Bruton Tyrosine Kinase Inhibitors (BTK), Pharmaceutical Composition and Method for decreasing the activity of BTK； method to treat cancers and inflammatory autoimmune disorders, such as rheumatoid arthritis, systemic lupus erythematosus, dermat ITIS atopic and Leukemia or Lymphoma. <； / p >；LA SOLICITUD SE REFIERE A UN COMPUESTO 3-ISOPROPOXI-N-2-METIL-4-1-METIL-1H-PIRAZOL-4-ILAMINOPIRIMIDIN-4-ILBENCILAZETIDINA-1-CARBOXAMIDA , ÚTIL EN EL TRATAMIENTO DE ENFERMEDADES ONCOLÓGICA, NEUROLÓGICAS E INMUNOLÓGICAS.
